Literature DB >> 2493980

Sensitivities of monolayers and spheroids of the human bladder cancer cell line MGH-U1 to the drugs used for intravesical chemotherapy.

R Knuchel1, F Hofstadter, W E Jenkins, J R Masters.   

Abstract

The in vitro cytotoxicities of the four drugs most frequently used for intravesical chemotherapy (Adriamycin, epodyl, mitomycin C, Thiotepa) and epirubicin were compared using monolayers and multicellular tumor spheroids of the human bladder cancer cell line, MGH-U1. Adriamycin and epirubicin were most cytotoxic against monolayer cultures, whereas mitomycin C killed more cells in spheroids. Epodyl was least cytotoxic against both two- and three-dimensional cultures. Thiotepa was the only drug more cytotoxic to three- than two-dimensional cultures. Topographic analysis of bromodeoxyuridine-stained nuclei using image analysis indicated that Adriamycin selectively removed or killed superficial cells in multicellular tumor spheroids, but had little effect on DNA synthesis within the spheroids. In contrast Thiotepa killed cells throughout the spheroids. These in vitro data appear to reflect clinical experience using intravesical chemotherapy to treat superficial bladder cancer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2493980

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

Review 1.  Modeling human bladder cancer.

Authors:  Cassandra Ringuette-Goulet; Stéphane Bolduc; Frédéric Pouliot
Journal:  World J Urol       Date:  2018-06-14       Impact factor: 4.226

Review 2.  Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy.

Authors:  Geeta Mehta; Amy Y Hsiao; Marylou Ingram; Gary D Luker; Shuichi Takayama
Journal:  J Control Release       Date:  2012-05-18       Impact factor: 9.776

Review 3.  Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.

Authors:  G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

4.  Furosemide reverses multidrug resistance status in bladder cancer cells in vitro.

Authors:  A G Speers; B A Lwaleed; J M Featherstone; B J Sallis; A J Cooper
Journal:  J Clin Pathol       Date:  2006-03-23       Impact factor: 3.411

Review 5.  Epirubicin: a review of its intravesical use in superficial bladder cancer.

Authors:  S V Onrust; L R Wiseman; K L Goa
Journal:  Drugs Aging       Date:  1999-10       Impact factor: 4.271

6.  Inhibition of hexokinase-2 with targeted liposomal 3-bromopyruvate in an ovarian tumor spheroid model of aerobic glycolysis.

Authors:  Srujan Kumar Gandham; Meghna Talekar; Amit Singh; Mansoor M Amiji
Journal:  Int J Nanomedicine       Date:  2015-07-08

7.  A bladder cancer patient-derived xenograft displays aggressive growth dynamics in vivo and in organoid culture.

Authors:  Elise Y Cai; Jose Garcia; Yuzhen Liu; Funda Vakar-Lopez; Sonali Arora; Holly M Nguyen; Bryce Lakely; Lisha Brown; Alicia Wong; Bruce Montgomery; John K Lee; Eva Corey; Jonathan L Wright; Andrew C Hsieh; Hung-Ming Lam
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

8.  Advanced cell culture techniques for cancer drug discovery.

Authors:  Carrie J Lovitt; Todd B Shelper; Vicky M Avery
Journal:  Biology (Basel)       Date:  2014-05-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.